Hyperlipoproteinemia Type IV: Clinical Trials

2 trials for Hyperlipoproteinemia Type IV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Hyperlipoproteinemia Type IV: new trials by email Literature Review of Hyperlipoproteinemia Type IV trials Research Report on Hyperlipoproteinemia Type IV

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Triglyceride Lowering Study
Omega-3-Acid Ethyl Esters - Hypertriglyceridemia
Phase 4UnknownJewish Hospital, Cincinnati, Ohio252009-07-012009-07-08
Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
rosuvastatin - Hypertriglyceridemia, Hyperlipoproteinemia Type IV
Phase 4CompletedAstraZeneca3342007-01-012010-12-16

Narrower conditions

Hypertriglyceridemia (2)  ·  Hyperlipidemias (1)  ·  Hyperlipoproteinemia Type II (1)  ·  Hyperlipoproteinemia Type V (1)  ·  Hyperlipoproteinemias (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Dyslipidemias (2)  ·  Genetic Diseases, Inborn (2)  ·  Lipid Metabolism Disorders (2)  ·  Lipid Metabolism, Inborn Errors (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Hyperlipidemias (1)  ·  Hyperlipoproteinemias (1)

Interventions

Omacor (1)  ·  Rosuvastatin Calcium (1)

Sponsors

AstraZeneca (1)  ·  Jewish Hospital, Cincinnati, Ohio (1)

Countries

Mexico (1)  ·  United States (1)

Top investigators

Ana Polanco, MD (1)  ·  Charles Glueck, MD (1)  ·  Juan Talavera, MD (1)

Results publications

PMID 23323877